Top 10 Small Cap Stocks To Buy Right Now

Small cap cybersecurity stock FireEye Inc (NASDAQ: FEYE) reported Q2 2017 earnings after the market closed Tuesday with results beating expectations as the Company benefited from its shift to a subscription and service-based model. Revenue increased 6% to $185.5 million (above the guidance range of $173 million to $179 million) and billings fell 12% to $172.0 million (near the high end of the guidance range of $155 million to $175 million). The net loss was $70.732 million versus a net loss of $139.320 million. The CEO commented:

“We executed well against our priorities in the second quarter, delivering billings, revenue, earnings per share and operating cash flow above expectations. We have made great progress rationalizing our cost structure, and reduced our operating losses by more than $100 million in the first six months of the year compared to the first six months of 2016. As we look forward to the second half of 2017, we are focused on new opportunities to expand our customer base with our Helix platform, our next generation endpoint protection, and innovations in our network and email security solutions.”

Top 10 Small Cap Stocks To Buy Right Now: Sky-mobi Limited(MOBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media coverage about Sky-mobi (NASDAQ:MOBI) has trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sky-mobi earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news stories about the software maker an impact score of 45.6853785900783 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Ethan Ryder]

    Mobius (CURRENCY:MOBI) traded 1.2% lower against the dollar during the 1-day period ending at 14:00 PM E.T. on August 21st. In the last week, Mobius has traded down 1.1% against the dollar. One Mobius token can now be bought for about $0.0291 or 0.00000452 BTC on popular cryptocurrency exchanges including GOPAX, BitMart, Gate.io and Stellar Decentralized Exchange. Mobius has a total market capitalization of $11.23 million and approximately $78,528.00 worth of Mobius was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded 12.4% lower against the US dollar during the 24 hour period ending at 17:00 PM E.T. on September 25th. One Mobius token can now be bought for approximately $0.0265 or 0.00000414 BTC on major cryptocurrency exchanges including Gate.io, Kucoin, BitMart and GOPAX. Over the last week, Mobius has traded up 8.8% against the US dollar. Mobius has a market cap of $10.22 million and approximately $69,762.00 worth of Mobius was traded on exchanges in the last day.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded up 0.1% against the dollar during the 24 hour period ending at 18:00 PM ET on February 11th. In the last week, Mobius has traded 3.1% lower against the dollar. One Mobius token can now be bought for approximately $0.0095 or 0.00000260 BTC on exchanges including OTCBTC, Gate.io, Stellar Decentralized Exchange and BitMart. Mobius has a total market capitalization of $4.89 million and approximately $19,445.00 worth of Mobius was traded on exchanges in the last day.

Top 10 Small Cap Stocks To Buy Right Now: ATA Inc.(ATAI)

Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top 10 Small Cap Stocks To Buy Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Shane Hupp]

    News articles about Achillion Pharmaceuticals (NASDAQ:ACHN) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Achillion Pharmaceuticals earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.941587509483 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Small Cap Stocks To Buy Right Now: Petroquest Energy Inc(PQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Small Cap Stocks To Buy Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its stake in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 842,775 shares of the transportation company’s stock after selling 13,507 shares during the quarter. State of Tennessee Treasury Department owned about 0.11% of Canadian National Railway worth $61,565,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Equities research analysts at Desjardins boosted their Q3 2018 earnings per share estimates for shares of Canadian National Railway in a research note issued on Monday, October 8th. Desjardins analyst B. Poirier now anticipates that the transportation company will earn $1.09 per share for the quarter, up from their previous forecast of $1.09. Desjardins also issued estimates for Canadian National Railway’s FY2021 earnings at $5.66 EPS.

  • [By Logan Wallace]

    Northwestern Mutual Wealth Management Co. grew its holdings in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 134,917 shares of the transportation company’s stock after acquiring an additional 1,692 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Canadian National Railway were worth $11,030,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Compass Capital Management Inc. bought a new position in Canadian National Railway (NYSE:CNI) (TSE:CNR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,535 shares of the transportation company’s stock, valued at approximately $207,000.

Top 10 Small Cap Stocks To Buy Right Now: FuelCell Energy Inc.(FCEL)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap fuel cell stock FuelCell Energy Inc (NASDAQ: FCEL) reported Q4 and fiscal year ended October 31, 2017 earnings with Q4 total revenues being $47.9 million versus $24.5 million:    

  • [By Scott Levine]

    Beyond that, there are numerous stocks, like IAMGOLD (NYSE: IAG) and FuelCell Energy (NASDAQ: FCEL), which I’m certain will not only remain absent from my portfolio but from my watchlist as well. Here’s why:

  • [By Shane Hupp]

    FuelCell Energy (NASDAQ: FCEL) is one of 25 public companies in the “Miscellaneous electrical machinery, equipment, & supplies” industry, but how does it contrast to its peers? We will compare FuelCell Energy to related companies based on the strength of its risk, dividends, earnings, valuation, profitability, analyst recommendations and institutional ownership.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on FuelCell Energy (FCEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    FuelCell Energy (NASDAQ: FCEL) and HRG Group (NYSE:HRG) are both oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 17.8% in short interest during the period. Some 6.9 million shares were short as of May 15. The stock closed at $1.88 on Thursday, down about 1.1% for the day, in a 52-week range of $0.93 to $2.49. Shares traded up about 1.4% in the short interest period, and days to cover rose from eight to 14.

Leave a Reply

Your email address will not be published. Required fields are marked *